Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma

Abstract: Background and Objective: Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIs) are effective against lung adenocarcinoma. However, limited data is available assessing the effectiveness of EGFR-TKI use in preventing re-accumulation of MPE. To our knowledge, there is no li...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Curr Drug Discov Technol
Glavni autori: Verma, Akash, Chopra, Akhil, Lee, Yeo W., Bharwani, Lavina D., Asmat, Atasha B., Aneez, Dokeu B.A, Akbar, Fazuludeen A., Lim, Albert Y.H., Chotirmall, Sanjay H., Abisheganaden, John
Format: Artigo
Jezik:Inglês
Izdano: Bentham Science Publishers 2016
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4997927/
https://ncbi.nlm.nih.gov/pubmed/27216707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570163813666160524142846
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items